Mutational activation of BRAF is not a major event in sporadic childhood papillary thyroid carcinoma

[1]  M. Nikiforova,et al.  Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas. , 2004, Cancer letters.

[2]  A. Pinchera,et al.  BRAFV599E Mutation Is the Leading Genetic Event in Adult Sporadic Papillary Thyroid Carcinomas , 2004 .

[3]  D. Clark,et al.  Mutational Analysis of BRAF in Fine Needle Aspiration Biopsies of the Thyroid: A Potential Application for the Preoperative Assessment of Thyroid Nodules , 2004, Clinical Cancer Research.

[4]  P. Ladenson,et al.  BRAF T1796A transversion mutation in various thyroid neoplasms. , 2004, The Journal of clinical endocrinology and metabolism.

[5]  V. Trovisco,et al.  BRAF mutations are associated with some histological types of papillary thyroid carcinoma , 2004, The Journal of pathology.

[6]  A. Pinchera,et al.  BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas. , 2004, The Journal of clinical endocrinology and metabolism.

[7]  M. Nikiforova,et al.  BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. , 2003, The Journal of clinical endocrinology and metabolism.

[8]  H. Namba,et al.  Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers. , 2003, The Journal of clinical endocrinology and metabolism.

[9]  Meenhard Herlyn,et al.  BRAF as a potential therapeutic target in melanoma and other malignancies. , 2003, Cancer cell.

[10]  P. Gattuso,et al.  Genomic DNA Extraction and PCR Amplification of Exon 15 of the BRAF Gene and Exons 1 and 2 of the NRAS Gene , 2003 .

[11]  V. Trovisco,et al.  BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC , 2003, Oncogene.

[12]  C. Pritchard,et al.  Raf proteins and cancer: B-Raf is identified as a mutational target. , 2003, Biochimica et biophysica acta.

[13]  P. Ladenson,et al.  BRAF mutation in papillary thyroid carcinoma. , 2003, Journal of the National Cancer Institute.

[14]  Yuri E Nikiforov,et al.  High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. , 2003, Cancer research.

[15]  J. Chan.  Strict criteria should be applied in the diagnosis of encapsulated follicular variant of papillary thyroid carcinoma. , 2002, American journal of clinical pathology.

[16]  A. Renshaw,et al.  Why there is the tendency to "overdiagnose" the follicular variant of papillary thyroid carcinoma. , 2002, American journal of clinical pathology.

[17]  M. Wiench,et al.  Molecular changes in thyroid neoplasia. , 2001, Folia histochemica et cytobiologica.

[18]  J. Rosai,et al.  Guest Editorial: Two Proposals Regarding the Terminology of Thyroid Tumors , 2000, International journal of surgical pathology.

[19]  H. Rabes,et al.  Molecular genetics of childhood papillary thyroid carcinomas after irradiation: high prevalence of RET rearrangement. , 1998, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[20]  Y. Nikiforov,et al.  Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. , 1997, Cancer research.

[21]  G. Williams,et al.  RET activation in adult and childhood papillary thyroid carcinoma using a reverse transcriptase-n-polymerase chain reaction approach on archival-nested material. , 1996, British Journal of Cancer.

[22]  V. Livolsi.  Unusual variants of papillary thyroid carcinoma. , 1995, Advances in endocrinology and metabolism.

[23]  A. Krattiger,et al.  What is 'Genetic Technology'? , 1994 .

[24]  J. Rosai.  Papillary carcinoma. , 2020, Monographs in pathology.

[25]  I. Hay,et al.  Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades. , 1988, Surgery.

[26]  R. Zaizov,et al.  Inhibition by Retinoic Acid of Myeloid Progenitors in Chronic Myeloid Leukemia and Myeloproliferative Disease: Increased Sensitivity in Blastic Phase of Chronic Myeloid Leukemia , 1988, Pathology.

[27]  A. Feinberg,et al.  Loss of genes on the short arm of chromosome 11 in bladder cancer , 1985, Nature.

[28]  J. Rosai,et al.  Papillary thyroid carcinoma: a study of its many morphologic expressions and clinical correlates. , 1985, Pathology annual.

[29]  J. Hazard,et al.  Relationship of the age of the patient to the natural history and prognosis of carcinoma of the thyroid. , 1953, Annals of surgery.